Insider Ledger
SGMT insider buying and SEC filings, explained
Sagimet Biosciences Inc. · CIK 1400118
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- 3-V Biosciences, Inc.
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$684K
Planned sales (10b5-1)
$4.2M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 14, 2026 | Planned (10b5-1) | George Kemble (Director) sold 350,987 shares at about $10.23 ($3.6M), marked as a 10b5-1 plan trade. Holdings down 85% to 62,161 shares. | SEC filing Filed Aug 17, 2026 |
| Aug 11, 2026 | Planned (10b5-1) | George Kemble (Director) sold 20,206 shares at about $9.95 ($201K), marked as a 10b5-1 plan trade. Holdings down 25% to 62,161 shares. | SEC filing Filed Aug 12, 2026 |
| Jul 20, 2026 | Sale | David Happel (CEO and Director) sold 64,051 shares at about $7.76 ($497K). Holdings down 8% to 741,570 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 22, 2026 |
| Jul 20, 2026 | Sale | Elizabeth Rozek (Chief Legal & Admin. Officer) sold 10,545 shares at about $7.76 ($82K). Holdings down 4% to 224,414 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 22, 2026 |
| Jul 20, 2026 | Planned (10b5-1) | George Kemble (Director) sold 18,844 shares at about $7.46 ($141K), marked as a 10b5-1 plan trade. Holdings down 23% to 62,161 shares. | SEC filing Filed Jul 22, 2026 |
| Feb 10, 2026 | Sale | David Happel (CEO and Director) sold 12,101 shares at $5.36 ($65K). Holdings down 2% to 677,621 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 12, 2026 |
| Feb 10, 2026 | Sale | Thierry Chauche (CFO) sold 1,312 shares at $5.36 ($7K). Holdings down 8% to 15,688 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 12, 2026 |
| Feb 10, 2026 | Sale | Eduardo Bruno Martins (Chief Medical Officer) sold 3,640 shares at $5.36 ($20K). Holdings down 3% to 103,296 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 12, 2026 |
| Feb 10, 2026 | Sale | Elizabeth Rozek (Chief Legal & Admin. Officer) sold 2,622 shares at $5.36 ($14K). Holdings down 1% to 190,959 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 12, 2026 |
| Nov 20, 2025 | Planned (10b5-1) | George Kemble (Chair and Director) sold 37,688 shares at about $7.69 ($290K), marked as a 10b5-1 plan trade. Holdings down 32% to 81,005 shares. | SEC filing Filed Nov 21, 2025 |
18 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow SGMT in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.